Author(s):
Siva Kumar Nemala, Pravallika Prava, Girija Sastry Vedula
Email(s):
nemalasivakumar@gmail.com
DOI:
10.52711/0974-360X.2023.00532 
Address:
Siva Kumar Nemala*, Pravallika Prava, Girija Sastry Vedula
Department of Pharmaceutical Chemistry, College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 7,
Year - 2023
ABSTRACT:
Tuberculosis is the world's most common cause of infectious disease death. Currently available drugs are not working properly on these strains. Therefore novel medications are required to treat T.B. several bisdihydropyrazole derivatives are docked against the T.B. protein. This study aims to provide potential bisdihydropyrazole derivatives are an effective inhibitors on T.B. protein by using computational study. Computational screening was performed for 14 synthetic bisdihydropyrazoles against novel target of T.B. and evaluate the toxicity studies by using Swiss adme. 14 synthetic bisdihydropyrazole derivatives as shown excellent docking score on PDB 1P44 compared to standard ligand. Out of 14 derivatives 13A shown -11.281 glide score and also shown excellent ADME/T propertiesCADD is the powerful tool for identifying and optimising lead molecules. Based on docking and ADMET studies bisdihydropyrazole may be have anti tubercular activity. It may be validated through In-vitro and In-vivo studies
Cite this article:
Siva Kumar Nemala, Pravallika Prava, Girija Sastry Vedula. Discovery of Structural prospects of novel bis di hydro pyrazole derivatives as Antitubercular agents: A Computational approach. Research Journal of Pharmacy and Technology 2023; 16(7):3239-4. doi: 10.52711/0974-360X.2023.00532
Cite(Electronic):
Siva Kumar Nemala, Pravallika Prava, Girija Sastry Vedula. Discovery of Structural prospects of novel bis di hydro pyrazole derivatives as Antitubercular agents: A Computational approach. Research Journal of Pharmacy and Technology 2023; 16(7):3239-4. doi: 10.52711/0974-360X.2023.00532 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-7-29
REFERENCES:
1. Das A. Aiming for a tuberculosis-free India: Perspective of a highly endemic Particularly Vulnerable Tribal Group (PVTG). Clinical Epidemiology and Global Health. 2021;9:69-70.doi.org/10.1016/j.cegh.2020.07.001.
2. Shruthi TG, Eswaran S, Shivarudraiah P, Narayanan S, Subramanian S. Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1, 2, 4-oxadiazole moiety. Bioorganic & Medicinal Chemistry Letters. 2019 Jan 1;29(1):97-102.doi.org/10.1016/j.bmcl.2018.11.002
3. Sriroopreddy R, Raghuraman P, Rajkumari RB. Modeling and docking study of GABA-AT protein in Mycobacterium tuberculosis-a computational approach. Research Journal of Pharmacy and Technology. 2018;11(4):1283-8. doi.org/10.5958/0974-360X.2018.00238.X.
4. Zine S, Patankar SA, Raopati SS. Rise of antibiotic resistance in tuberculosis. Research Journal of Pharmacy and Technology. 2018 Jul 1;11(7):3201-4. doi.org/10.5958/0974-360X.2018.00588.7.
5. Muthukumaran P, Rajiniraja M. In silico binding study of bioactive Hispolon and its Analogues to mycobacterial mtfabH. Research Journal of Pharmacy and Technology. 2017 Jul 1;10(7):2229-32. doi.org/10.5958/0974-360X.2017.00394.8
6. Ghori SS, Quddus MA, Khalid H. A clinical study of acute kidney injury on using antituberculosis drugs in geriatrics. Research Journal of Pharmacy and Technology. 2017;10(6):1746-50. doi.org/10.5958/0974-360X.2017.00308.0
7. Zemlyansky OA, Tyurina EB, Bashkirev AA, Kalyuzhnaya EV, Zemlyanskaya LO. Experience and Efficiency of Laboratory Diagnosis of Tuberculosis with PCR Detector System GeneXpert in Belgorod Region. Research Journal of Pharmacy and Technology. 2017;10(3):743-6. doi.org/10.5958/0974-360X.2017.00139.1
8. Xavier AS, Lakshmanan M. Delamanid: A new armor in combating drug-resistant tuberculosis. Journal of Pharmacology and Pharmacotherapeutics. 2014 Sep;5(3):222-4. doi.org/10.4103/0976-500X.136121
9. Ramachandran S, Aanandhi MV, Cheriyan BV. Assessment of Antitubercular Activity-A Review. Research Journal of Pharmacy and Technology. 2019;12(8):3973-8. doi.org/ 10.5958/0974-360X.2019.00684.X
10. Surakanti R, Eppakayala L, Merugu R, Pendyala VR. Synthesis and Molecular docking for Anti-Inflammatory and Anti Mitotic activities of (S)-(2-Methyl-4-(1-Phenyl-1h-Thieno/Furan [3, 2-C] Pyrazol-3-yl) Piperazin-1-yl)(Pyridin-2-yl) Methanone. Asian Journal of Research in Chemistry. 2017 Jul 1;10(4):582-6.doi.org/ 10.5958/0974-4150.2017.00097.9
11. Thorat BR, Nazirkar B, Thorat VB, More K, Jagtap R, Yamgar R. Synthesis, SAR, Molecular Docking and Anti-TB study of 3-Hydroxy-1-Benzofuran-2-Carbohydrazide. Asian Journal of Research in Chemistry. 2016;9(3):116-26. doi.org/ 10.5958/0974-4150.2016.00021.3
12. Karad SC, Purohit VB, Thakor P, Thakkar VR, Raval DK. Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities. European Journal of Medicinal Chemistry. 2016;112:270-9.doi.org/10.1016/j.ejmech.2016.02.016
13. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry. 2004 Mar 25;47(7):1750-9.doi.org/10.1021/jm030644s
14. Şimşek Y, Baran SS, Aslım B. In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals. Journal of Molecular Graphics and Modelling. 2021 Dec 1;109:108038.doi.org/10.1016/j.jmgm.2021.108038
15. Astolfi A, Felicetti T, Iraci N, Manfroni G, Massari S, Pietrella D, Tabarrini O, Kaatz GW, Barreca ML, Sabatini S, Cecchetti V. Pharmacophore-based repositioning of approved drugs as novel Staphylococcus aureus NorA efflux pump inhibitors. Journal of Medicinal Chemistry. 201723;60(4):1598-604.doi.org/10.1021/acs.jmedchem.6b01439
16. Palomo V, Perez DI, Roca C, Anderson C, Rodríguez-Muela N, Perez C, Morales-Garcia JA, Reyes JA, Campillo NE, Perez-Castillo AM, Rubin LL. Subtly modulating glycogen synthase kinase 3 β: allosteric inhibitor development and their potential for the treatment of chronic diseases. Journal of Medicinal Chemistry. 201722;60(12):4983-5001.doi.org/10.1021/acs.jmedchem.7b00395
17. ul Qamar MT, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis. 2020;10(4):313-9.doi.org/10.1016/j.jpha.2020.03.009
18. Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry. 2015 14;58(9):4066-72.doi.org/10.1021/acs.jmedchem.5b00104.
19. Kuo MR, Morbidoni HR, Alland D, Sneddon SF, Gourlie BB, Staveski MM, Leonard M, Gregory JS, Janjigian AD, Yee C, Musser JM. Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data. Journal of Biological Chemistry. 2003;278(23):20851-9. doi.org/10.1074/jbc.M211968200
20. Tanitame A, Oyamada Y, Ofuji K, Terauchi H, Kawasaki M, Wachi M, Yamagishi JI. Synthesis and antibacterial activity of a novel series of DNA gyrase inhibitors: 5-[(E)-2-arylvinyl] pyrazoles. Bioorganic and Medicinal Chemistry Letters. 2005;15(19):4299-303.doi.org/10.1016/j.bmcl.2005.06.103
21. Nayak N, Ramprasad J, Dalimba U. New INH–pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 2015;25(23):5540-5.doi.org/10.1016/j.bmcl.2015.10.057
22. Machado AT, Silva M, Iulek J. Structural studies of glyceraldehyde-3-phosphate dehydrogenase from Naegleria gruberi, the first one from phylum Percolozoa. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics. 2018;1866(5-6):581-8.doi.org/10.1016/j.bbapap.2018.02.006
23. Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry. 2015;58(9):4066-72.doi.org/10.1021/acs.jmedchem.5b00104
24. Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Research. 2018;46(W1):W257-63.doi.org/10.1093/nar/gky318
25. Chelamalla R, Makula A. Molecular docking studies and ADMET predictions of pyrimidine coumarin scaffolds as potential IDO inhibitors. Asian Journal of Research in Chemistry. 2017;10(3):331-40. doi.org/ 10.5958/0974-4150.2017.00056.6